MCD
Clinical trials for MCD explained in plain language.
Never miss a new study
Get alerted when new MCD trials appear
Sign up with your email to follow new studies for MCD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug could help protect kidneys in autoimmune diseases
Disease control Recruiting nowThis study tests a drug called atacicept in 200 adults and teens with several autoimmune kidney diseases, including IgA nephropathy and focal segmental glomerulosclerosis. The goal is to see if it safely reduces protein in the urine and helps preserve kidney function. Participant…
Matched conditions: MCD
Phase: PHASE2 • Sponsor: Vera Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New kidney drug candidate takes first step in human trials
Knowledge-focused Recruiting nowThis early-stage study is testing a new oral drug called SK-09 in 72 healthy adults to see if it is safe and how the body processes it. The trial is the first time SK-09 is given to humans, and it does not aim to treat any disease yet. Results will help decide if further studies …
Matched conditions: MCD
Phase: PHASE1 • Sponsor: Consun Pharmaceutical Group • Aim: Knowledge-focused
Last updated May 26, 2026 05:06 UTC
-
New study aims to unlock mysteries of kidney disease return after transplant
Knowledge-focused Recruiting nowThis study gathers information and biological samples from 300 people with FSGS or MCD who have had or will have a kidney transplant. Researchers want to learn why these kidney diseases sometimes come back after transplant and how to improve treatment. Participants provide data o…
Matched conditions: MCD
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 26, 2026 05:02 UTC
-
Personalized trial matching could revolutionize kidney care
Knowledge-focused Recruiting nowThis study helps people with nephrotic syndrome and related kidney diseases find clinical trials that may be a good fit for their specific condition. Researchers use detailed molecular information from each participant to recommend targeted therapies being tested in other studies…
Matched conditions: MCD
Phase: NA • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 26, 2026 05:01 UTC